Anticipated Shortage

MINT-ENTACAPONE

MINT PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MINT-ENTACAPONE in Canada?

A shortage of MINT-ENTACAPONE 200MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated July 28, 2026), but it has not started yet.

Why is MINT-ENTACAPONE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MINT-ENTACAPONE be available again?

The manufacturer's estimated resolution date is January 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file4 products

Expected resolution~4 months remaining (estimate)

Affected strength200MG

Last updated2026-07-28

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

AURO-ENTACAPONE

AURO PHARMA INC

200MG · DIN 02431602

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ ENTACAPONE

SANDOZ CANADA INCORPORATED

200MG · DIN 02380005

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

APO-ENTACAPONE

APOTEX INC

200MG · DIN 02321459

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-ENTACAPONE

TEVA CANADA LIMITED

200MG · DIN 02375559

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2027-01-31

~4 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02535939

Strength

200MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ENTACAPONE

Tier

Unrated

Last Updated

2026-07-28

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from MINT PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

300MG · DIN 02480956

25MG · DIN 02468859

10MG · DIN 02468840

200MG · DIN 02524708

800MG · DIN 02524724

400MG · DIN 02524716